Zobrazeno 1 - 10
of 162
pro vyhledávání: '"K, Linnainmaa"'
Autor:
K. Linnainmaa, Karin Mattson, K Husgafvel-Pursiainen, H Vainio, Sirkku T. Saarikoski, K Koskinen, Ari Hirvonen
Publikováno v:
JNCI Journal of the National Cancer Institute. 88:1853-1856
Background Humans vary in their ability to metabolize endogenous and exogenous compounds. Glutathione S-transferases (GSTs) and N-acetyltransferases (NATs) are enzymes involved in the detoxification of hazardous agents. The GSTM1 and GSTT1 genes exhi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(11)
We investigated apoptosis and the expression of bcl-2, mcl-1, bcl-X, and bax in histological sections from 35 malignant mesotheliomas and 21 metastatic adenocarcinomas. Moreover, the expression of bcl-2, mcl-1, bcl-X, and bax were assessed by Western
Autor:
J R, Testa, M, Carbone, A, Hirvonen, K, Khalili, B, Krynska, K, Linnainmaa, F D, Pooley, P, Rizzo, V, Rusch, G H, Xiao
Publikováno v:
Cancer research. 58(20)
Exposure to the carcinogen asbestos is a major factor in the development of malignant mesothelioma. However, not all mesotheliomas are associated with asbestos exposure, and only a small minority of people exposed to asbestos develop mesothelioma. Th
Publikováno v:
Acta oncologica (Stockholm, Sweden). 35(4)
The present study was carried out in order to examine the radiosensitivity of malignant pleural mesothelioma cell lines. Cell kinetics, radiation-induced delay of the cell cycle and DNA ploidy of the cell lines were also determined. For comparison an
Publikováno v:
Cancer research. 55(14)
Besides asbestos exposure, the factors that determine susceptibility to malignant mesothelioma are unknown. We evaluated the risk of GSTM1 null genotype and slow acetylation-associated NAT2 genotype for malignant mesothelioma in relation to asbestos
Autor:
L, Hagmar, A, Brøgger, I L, Hansteen, S, Heim, B, Högstedt, L, Knudsen, B, Lambert, K, Linnainmaa, F, Mitelman, I, Nordenson
Publikováno v:
Cancer research. 54(11)
Cytogenetic assays in peripheral blood lymphocytes (PBL) have been used extensively to survey the exposure of humans to genotoxic agents. The conceptual basis for this has been the hypothesis that the extent of genetic damage in PBL reflects critical
Autor:
A, Hand, K, Pelin, M, Halme, A, Ekman, M, Mattson, M, Vallas, K, Mattson, K, Linnainmaa, K, Husgafvel-Pursiainen
Publikováno v:
Anti-cancer drugs. 4(3)
Non-small cell lung cancers (NSCLC) are often resistant to chemotherapy. Cisplatin has shown the most activity against all the histological subtypes and is now used in most combined treatment programmes. Interferon (IFN)-alpha has been shown to poten
Autor:
R A, Metcalf, J A, Welsh, W P, Bennett, M B, Seddon, T A, Lehman, K, Pelin, K, Linnainmaa, L, Tammilehto, K, Mattson, B I, Gerwin
Publikováno v:
Cancer research. 52(9)
Twenty cell lines from 17 individuals with malignant mesothelioma have been examined for p53 alterations by direct sequencing of genomic DNA, by evaluation of mRNA expression levels, and by immunocytochemical analysis of p53 protein expression in com
Autor:
A, Brøgger, L, Hagmar, I L, Hansteen, S, Heim, B, Högstedt, L, Knudsen, B, Lambert, K, Linnainmaa, F, Mitelman, I, Nordenson
Publikováno v:
Cancer genetics and cytogenetics. 45(1)
To investigate whether high rates of chromosomal aberrations (CAs), sister chromatid exchange (SCE), or micronuclei(MN) in peripheral lymphocytes indicate an increased risk for subsequent cancer, a prospective cohort study of 2,969 subjects cytogenet
Autor:
Curtis C. Harris, T.K. Smith, Brenda I. Gerwin, P. Hussain, E Spillare, A. Okamoto, Edward Gabrielson, Harvey I. Pass, S. Ungar, Koichi Hagiwara, K. Linnainmaa, Karin Mattson
Publikováno v:
Lung Cancer. 15:260-261